复方华蟾胶囊抗小鼠肿中瘤作用的实验研究

目的了解复方华蟾胶囊抗小鼠移植性肿瘤的作用.方法以小鼠肝癌22(H22)、小鼠肉瘤180(S180)为瘤株,应用动物移植性肿瘤的体内试验法对药物进行抗癌药效学试验.结果复方华蟾胶囊灌胃4,2 g/kg@d,连续14 d,对小鼠移植性肝癌实体型生长有明显的抑制作用,抑瘤率分别为38.09%,30.95%.对小鼠移植性S180实体型生长有明显的抑制作用,抑瘤率分别为34.7%,30.08%.复方华蟾胶囊对荷瘤小鼠的胸腺和脾脏重量无影响.结论复方华蟾胶囊在试验条件下有一定抗肿瘤作用.     

起搏后体位性低血压

观察7条狗起搏前后从卧位变为站位时的血流动力学变化。起搏后起立时平均动脉压平均下降28％,是正常时(13％)的二倍,并且恢复时间明显延长(P<0.01)。实验表明起搏前后狗的体位性低血压代偿机制不同,正常时起立时心输出量增加20％左右,心率平均增加24％,而每搏输出量在开始阶段常减少,有的在整个站立过程中减少。心率在提高心输出量,代偿体位性低血压中起着重要作用。起搏后由于心率固定不变,因而出现明显的体位性低血压。提高起搏频率可改善体位性低血压。     

The Inhibited Power Motive,Type A Behavior,and Patterns of Cardiovascular Response During the Structured Interview and Thematic Apperception Test

Abstract

The Type A behavior pattern and the inhibited power motive have been implicated in the development of coronary heart disease (CHD). Since it is widely believed that enhanced cardiovascular responsivity may be one mechanism by which individuals develop CHD, the present study examined the relationship of Type A behavior and the inhibited power motive to different patterns of cardiovascular response during two behavioral tasks. Forty-one (24 Type A's, 17 Type B's) male undergraduates underwent the Type A structured interview (SI) and the Thematic Apperception Test (TAT) while a broad range of cardiovascular functions were simultaneously recorded. Different patterns of cardiovascular response were observed during the SI and TAT, and Type A's showed a greater tendency than Type B's to exhibit increased heart rate (HR), systolic blood pressure (SBP), and forearm blood flow (FBF) during the SI and the preparatory phase (but not the story-telling phase) of the TAT. The inhibited power motive was not related to enhanced cardiovascular responsivity during the SI or TAT. The implications of these findings for the development of CHD are discussed.     

Male orgasmic disorder: a new look at an old problem

The past decades have seen remarkable progress in the diagnosis and treatment of male sexual dysfunctions. One vexing problem, which remains stubbornly not amenable to intervention, is what Diagnostic and Statistical Manual jargon currently refers to as Male Orgasmic Disorder (MOD). This article suggests an alternate understanding of the factors contributing to this condition and offers a practice-tested treatment protocol based on this perspective. Not included as a focus is orgasmic/ejaculatory disorder that results from illness, injury, substance abuse or medication side-effects. In contrast to existing pathology models, I suggest that MOD is the result of a conflict between two positive messages heard by most sexually active people, yet for these men, no resolution has been discovered. The following treatment protocol has been developed with an understanding that two values stances – self-control and release – are inherently positive and attempting to tamper with either of them may produce confusion and resistance. Instead, the therapist seeks to create a physical sensation, which could best be described as “controlled release”.     

Sustained Release of Minocycline From Minocycline-Calcium-Dextran Sulfate Complex Microparticles for Periodontitis Treatment

It is important to address the periodontitis-associated bacteria in the residual subgingival plaque after scaling and root planing to successfully treat periodontitis. In this study, we explored the possibility of exploiting the ion pairing/complexation of minocycline, Ca²⁺, and sulfate/sulfonate-bearing biopolymers to develop an intrapocket delivery system of minocycline as an adjunct to scaling and root planing. Minocycline-calcium-dextran sulfate complex microparticles were synthesized from minocycline, CaCl₂, and dextran sulfate. They were characterized using Fourier-transform infrared spectroscopy, scanning electron microscopy, and energy-dispersive X-ray spectroscopy. An in vitro release study was conducted to evaluate the release kinetics of minocycline from these microparticles. Agar disk diffusion assays and biofilm-grown bacteria assays were used to assess antibacterial capability. High loading efficiency (96.98% ± 0.12%) and high loading content (44.69% ± 0.03%) for minocycline were observed for these complex microparticles. Mino-Ca-DS microparticles achieved sustained release of minocycline for at least 9 days at pH 7.4 and 18 days at pH 6.4 in phosphate-buffered saline, respectively. They also demonstrated potent antimicrobial effects against Streptococcus mutans and Aggregatibacter actinomycetemcomitans in agar disk diffusion and biofilm assays. These results suggested that the ion pairing/complexation of minocycline, Ca²⁺, and sulfonate/sulfate-bearing biopolymers can be exploited to develop complex microparticles as local delivery systems for periodontitis treatment.     

Identification and analysis of the reactive metabolites related to the hepatotoxicity of safrole

1.?Safrole is the main component of the volatile oil in Xixin, which has a strong antifungal effect. However, safrole has been shown to be associated with the development of hepatocellular carcinoma. Methylenedioxyphenyl and allyl-benzene substructures of safrole may cause a mechanism-based inhibition (MBI) of CYP450 enzymes (CYPs) and produce reactive metabolites (RMs), resulting in inhibition of enzyme activity and toxic effects.

2.?Based on the experiments of CYPs cocktail screening, glutathione (GSH) capture and the IC₅₀ data, we found that safrole had an inhibitory effect on CYP1A2. The test of enzyme activity recovery when adding GSH may help to verify the MBI of safrole.

3.?Two metabolites, 1,2-dihydroxy-4-allylbenzene (M1) and 1′-hydroxy safrole (M2) could be captured by GSH. The ultra performance liquid chromatography - tandem mass spectrometer (UPLC-MS/MS) method was used to identify the RMs through a detailed characterization of the safrole cleavage processes and the GSH-M1 adduct. The RMs identified are quinone and its tautomer. Thus, preliminary conclusion can be obtained that safrole is a mechanism-based inhibitor of CYP1A2.

4.?The cleavage process of the GSH-M1/M2 adduct was analyzed in further detail. We believe the safrole hepatotoxicity mechanism is related to the RMs mediated by CYP1A2. This work provides important information on predicting in vivo drug induced liver injury.     

Induction of apoptosis and autophagy in metastatic thyroid cancer cells by valproic acid (VPA)

The present study investigated the effect of valproic acid (VPA) on the inhibition of RET signaling and induction of apoptosis in human thyroid carcinoma cells. VPA inhibited the viability of ARO and WRO cells and also inhibited cyclin D1 and caused caspase-3 cleavage. VPA decreased the level of RET protein and blocked the activation of RET downstream targets including phosphorylated ERK, phosphorylated AKT, and p70S6K/pS6. VPA induced metabolic stress, activated AMP-activated protein kinase and increased autophagic flux. Pharmacological inhibition of autophagy (chloroquine) augmented VPA-inducible cytotoxicity, suggesting that autophagy was protective in VPA-treated cells. VPA has a wide spectrum of activity against human thyroid carcinoma cells, and its cytotoxicity can be augmented by inhibiting autophagy. Expression of VPA molecular targets in metastatic human thyroid carcinoma cells suggests that VPA has a potential to become a thyroid cancer therapeutic agent.     

消咳汤治疗感冒后干咳症81例

咳嗽是冬春季节的常见病、多因感冒而引起,常用止咳药与抗生素治疗,虽有一定效果,但有些患者外感症状解除后,咳嗽持久不愈,且多为干咳,伴有少量的粘痰,咽红干痒或痛而不适,舌苔薄白或薄黄,或稍厚或欠润,脉象正常.     

金愈汤治疗慢性支气管炎急性发作60例

慢性支气管炎急性发作是临床常见病、多发病.近年来,我们应用金愈汤治疗60例,取得较好的疗效,报告如下.     

谷晓红运用银莱汤加减治疗小儿发热

银莱汤由金银花、连翘、莱菔子等多味药组成,其功效为清肺泄胃、宣肺止咳、辛凉清解、调和表里,临床常运用于治疗外感热病,兼有饮食不消、纳谷不香的患者。谷晓红教授以银菜汤为基本方治疗小儿感冒发热、小儿肺炎喘嗽发热、小儿惊厥发热、小儿乳蛾发热,取其两清肺胃、消积化滞之效。